Showing 19,861 - 19,880 results of 199,471 for search '(( i a decrease ) OR ( 5 ((nn decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 2.52s Refine Results
  1. 19861

    Data_Sheet_1_Probiotics for the prevention and treatment of COVID-19: a rapid systematic review and meta-analysis.docx by Aruba Sohail (16013045)

    Published 2023
    “…When used prophylactically, probiotics did not decrease the incidence of COVID-19 cases (RR 0.65; 95% CI: 0.37–1.12; I<sup>2</sup> = 66%). …”
  2. 19862
  3. 19863
  4. 19864
  5. 19865

    Data_Sheet_1_The Nature of Noradrenergic Volume Transmission From Locus Coeruleus to Brainstem Mesencephalic Trigeminal Sensory Neurons.DOCX by Hiroki Toyoda (67813)

    Published 2022
    “…In contrast, 20 Hz activity induced by a 1-s pulse applied every 5–10 s caused only a transient facilitation of Ih inhibition followed by a forced termination of Ih inhibition. …”
  6. 19866
  7. 19867

    Zeólita NaA sintetizada sobre fibra de vidro como estratégia para otimização do abrandamento de águas duras by Edipo S Oliveira (12703399)

    Published 2022
    “…Water softening experiments, carried out in a continuous flow system, with a column containing the glass fiber-zeolite NaA, showed high performance in decreasing the Ca2+ ions, with complete removal achieved for 20 mL of simulated hard water (Ca2+ 100.0 mg L-1) by using 200 mg of the sample in form of column (10 mm diameter × 300 mm high). …”
  8. 19868
  9. 19869

    Quantifying the Contribution of Statins to the Decline in Population Mean Cholesterol by Socioeconomic Group in England 1991 - 2012: A Modelling Study by Chris Kypridemos (719751)

    Published 2015
    “…In our ‘no statins’ scenario we predicted a mean total cholesterol of 5.36 mmol/L (95% CI: 5.33-5.40) for 2011-12. …”
  10. 19870
  11. 19871
  12. 19872
  13. 19873
  14. 19874

    Efmoroctocog Alfa: A Review in Haemophilia A by James E. Frampton (4995257)

    Published 2021
    “…Efmoroctocog alfa was generally well tolerated; inhibitors occurred in approximately one-third of PUPs in a phase III study. Efmoroctocog alfa is an established and effective EHL FVIII replacement therapy for the management of haemophilia A. …”
  15. 19875
  16. 19876
  17. 19877
  18. 19878
  19. 19879
  20. 19880